DOI: 10.25881/BPNMSC.2019.90.19.013

Authors

Lebedev N.N., Shikhmetov A.N., Khabardokov A.Kh., Nagornyuk V.N.

MChU Branch Clinical Diagnostic Center of PJSC Gazprom, Moscow

Abstract

The authors analyzed the results of treatment of 68 patients with benign prostatic hyperplasia who underwent transurethral photoselective vaporization using a 80 watt Laserscope, San Jose, CA CT Green Light PVP laser under stationary substitution conditions. The average age of the patients was 63 years (from 57 to 67 years). Indications and contraindications to the implementation of this intervention in outpatient settings were determined. To do this, a multimodal, individualized approach to assessing the patient’s condition using all the necessary instrumental, laboratory and clinical survey methods was used. Particular attention was paid to assessing the severity of patients on the scale of the American Society of Anesthesiologists. The peculiarities of the technique of performing surgical intervention are considered. The results of treatment were assessed using the IPSS scale (before surgery – 23,7±1,5, after – 4,7±0,6), QoL quality of life index (before surgery – 4,7± 0,3, after – 1,2±0,1), assessment of the rate of urination (before the operation – 6,8±0,2 ml/s, after – 25,8±1,0 ml/s), ultrasound of the kidneys, bladder, prostate, uroflowmetry, as well as mixed cystourethrography and mixed ultrasound urethroscopy in combination with uroflowmetry. The received data testify to high efficiency and safety of application of transurethral photoselective vaporization of the prostate gland in stationary substitution conditions.

Keywords: prostate adenoma, photoselective vaporization, quality of life, stationary substitution technologies.

References

1. Apolihin, O.I., Sivkov, A.V., Moskaleva, N.G., Solnceva, T.V., Komarova, V.A. Analiz uronefrologicheskoj zabolevaemosti i smertnosti v Rossijskoj Federacii za desjatiletnij period (2002–2012) po dannym oficial’noj statistiki// Jeksperimental’naja i klinicheskaja urologija. 2014. № 2. Р. 4–12.

2. Volnuhin, A.V. Stacionarozameshhajushhie tehnologii v rabote vracha obshhej praktiki (semejnogo vracha): organizacionno-jekonomicheskie aspekty:diss. …kand.med.nauk. – M., 2010. – 199 р.

3. Golovko, S.V., Savickij, A.F. Klinicheskaja ocenka jeffektivnosti fotoselektivnoj vaporizacii prostaty so srednimi srokami nabljudenija//Medicinskie novosti. 2014. № 1. Р. 69–72.

4. Glybochko, P.V., Aljaev, Ju.G. Rossijskaja urologija v XXI v. // Urologija. 2015. № 5. Р. 4–9.

5. Davydov, D.S., Carichenko, D.G., Bezrukov, E.A., Suhanov, R.B., Vinarov, A.Z., Sorokin, N.I., Enikeev, D.V., Dymov, A.M., Danilov, S.P. Oslozhnenija gol’mievoj lazernoj jenukleacii giperplazii predstatel’noj zhelezy // Urologija. 2018. № 1. Р. 42–47.

6. Enikeev, D.V., Glybochko, P.V., Aljaev, Ju.G., Rapoport, L.M., Enikeev, M.Je., Carichenko, D.G., Sorokin, N.I., Suhanov, R.B., Dymov, A.M., Hamraev, O.H., Davydov, D.S., Taratkin, M.S., Simberdeev, R.R. Gol’mievaja lazernaja jenukleacija (HOLEP) pri giperplazii prostaty malen’kih, bol’shih i gigantskih razmerov. Prakticheskie rekomendacii. Opyt bolee 450 operacij // Urologija. 2016. № 4. Р. 63–69.

7. Zenkov, I.B. Organizacionnye aspekty medicinskoj pomoshhi licam starshego trudosposobnogo vozrasta s urologicheskimi zabolevanijami: dis. …kand.med.nauk. – M., 2014. – 160 р.

8. Korolev, S.V., Zenkov, I.B. Mediko–social’nye aspekty urologicheskoj patologii v megapolise // Social’nye aspekty zdorov’ja naselenija. 12.11.2013. Jel#FS77–28654.

9. Korneev I.A., Alekseeva T.A., Kogan M.I., Pushkar’ D.Ju. Jepidemiologija rasstrojstv mocheispuskanija u muzhchin Rossijskoj Federacii // Urologija. 2016. № 2 (supplement). Р. 70–75.

10. Merinov, D.S., Pavlov, D.A., Fatihov, R.R., Epishov, V.A. Na peredovyh rubezhah razvitija minimal’no-invazivnoj urologii // Jeksperimental’naja i klinicheskaja urologija. 2012. № 4. Р. 86–96.

11. Elshal, A., Shoma, A., El-Nahas, A., Nabeeh, A., Elkoushy, M., Carrier, S. and Elhilali, M. (2014). PD26-05 A Randomized trial comparing greenlight (xps) laser photoselective vapo-enucleation of the prostate (pvep) versus holmium laser enucleation of the prostate (holep) for treatment of benign prostate hyperplasia (BPH). // The Journal of Urology, 191(4), P. e760–e761. URL.

12. Kahokehr, A. Gilling, P. Holmium Enucleation of Prostate. Treatment of Benign Prostatic Hyperplasia: Modern Alternative to Transurethral Resection of the Prostate, 2014 pp.61-73. URL.

13. Large, T., Borofsky, M. and Lingeman, J. (2016). Re: Photoselective Vaporization of the Prostate for Benign Prostatic Hyperplasia Using the 180 Watt System: Multicenter Study of the Impact of Prostate Size on Safety and Outcomes and Re: GreenLight™ Laser (XPS) Photoselective Vapo-Enucleation versus Holmium Laser Enucleation of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia: A Randomized Controlled Study. // The Journal of Urology, 195(1), P. 228–231. URL.

14. van Rij, S. and Gilling, P. (2012). In 2013, Holmium Laser Enucleation of the Prostate (HoLEP) May Be the New ‘Gold Standard’. Current Urology Reports, 13(6), P. 427-432. URL.

For citation

Lebedev N.N., Shikhmetov A.N., Khabardokov A.Kh., Nagornyuk V.N. Photo-selective vaporization of the prostate gland in stationary substitution conditions. Bulletin of Pirogov National Medical & Surgical Center. 2019;14(1):63-67. (In Russ.) https://doi.org/10.25881/BPNMSC.2019.90.19.013